Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
Key Highlights
- ➤Cytokinetics (CYTK) announces three aficamten presentations at November 6 HCMS Scientific Sessions
- ➤ACACIA-HCM CMR study examines aficamten’s effects on cardiac structure and function in nonobstructive HCM
- ➤ACACIA-HCM presentation reports aficamten’s impact on patient-reported health status in nonobstructive HCM
- ➤FOREST-HCM analysis evaluates left ventricular systolic dysfunction during long-term aficamten therapy
- ➤Cytokinetics plans Q4 2026 Supplemental New Drug Application for aficamten in nonobstructive HCM
Expert Statements
Ahmad Masri, M.D., M.S.; Associate Professor of Medicine and Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University
“Effect of Aficamten on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study”
Michael E. Nassif, M.D.; Cardiologist, Saint Luke’s Mid America Heart Institute
“Effect of Aficamten on Patient-Reported Health Status in Non-Obstructive Hypertrophic Cardiomyopathy”
Daniele Massera, M.D.; Director, Hypertrophic Cardiomyopathy Program, NYU Langone Health, and Assistant Professor, Department of Medicine, NYU Grossman School of Medicine
“Left Ventricular Systolic Dysfunction in Long-Term Aficamten Therapy for Obstructive HCM: A FOREST-HCM Analysis”
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations, including two Late Breaking Oral Abstract presentations and one poster presentation, at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions, held in collaboration with the American Heart Association Scientific Sessions, taking place in Chicago, IL, November 6, 2026.
Title: Effect of Aficamten on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study Presenter: Ahmad Masri, M.D., M.S., Associate Professor of Medicine, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University Date: Friday, November 6, 2026 Session Title: Session 4 - Late Breaking Oral Abstracts Session Time: 2:15 PM – 3:15 PM CT Presentation Time: 2:30 PM – 2:40 PM CT Location: Room S406a
Get started
Create a free account to read the full story.